Georgios Matis – Top Global Advocate for Neuromodulation Excellence of the Year 2025
Georgios Matis , MD, MSc, PhD, FINR(CH) – Senior Consultant, Neurosurgery From the very beginning of his journey in neurosurgery, Dr. Georgios Matis was captivated by the intricate ways the nervous system shapes human experience, particularly in the realms of pain and movement disorders. His interest in neuromodulation was not solely driven by scientific curiosity but also by a deep commitment to improving the lives of those who suffer from chronic pain and spasticity. A turning point in his career came under the mentorship of Dr. A. Koulousakis, whose expertise in neuromodulation left a lasting impact. Under his guidance, Dr. Matis found himself drawn to a field where advanced technology meets compassionate patient care. This mentorship reinforced his belief in a patient-centered approach, emphasizing the importance of neuromodulation as a means to restore function and dignity for individuals who have exhausted conventional treatment options. Chronic pain and spasticity are not just clinical conditions; they impose profound limitations on every aspect of a person’s life. In his practice, Dr. Matis has witnessed firsthand how neuromodulation, through spinal cord stimulation, peripheral nerve stimulation, and intrathecal therapies, can offer life-changing relief. He has seen patients regain mobility, return to activities they once loved, and reclaim their independence. These transformations serve as a constant source of motivation, reinforcing his dedication to the field. For Dr. Matis, neurosurgery is about more than just surgical precision; it is about understanding the patient’s journey, offering hope where there was once despair, and continually expanding the boundaries of what is possible. As Aristotle once said, “Educating the mind without educating the heart is no education at all.” This philosophy holds in neuromodulation, where success is measured not just by medical advancements but by the real impact on a patient’s quality of life. There is no single “most effective” therapy in neuromodulation—each treatment has its role depending on the patient’s condition, pain type, and individual response. Spinal cord stimulation has proven particularly effective for conditions like persistent spinal pain syndrome (PSPS) and complex regional pain syndrome (CRPS), especially with the advent of closed-loop stimulation and novel waveforms. Peripheral nerve field stimulation provides an invaluable option for localized pain syndromes and cases where spinal cord stimulation may not be feasible. Meanwhile, intrathecal drug delivery, particularly with agents like ziconotide, is essential for patients who require targeted drug administration when systemic medications have failed or caused severe side effects. The key to effective pain management lies not in a one-size-fits-all approach but in carefully selecting the most suitable therapy for each patient. As Hippocrates wisely stated, “It is far more important to know what person the disease has than what disease the person has.” By combining the latest technological advancements with a profound understanding of patient needs, physicians can create personalized treatment strategies that ensure the best possible quality of life. For Dr. Matis, this balance between innovation and compassionate care remains the driving force behind his work in neuromodulation. The Future of Neuromodulation: Advancing Patient-Centered Care Neuromodulation is undergoing significant advancements, and Dr. Matis is proud to contribute to its evolution through research and clinical practice. Several developments are shaping the field, particularly those that enhance personalization, improve patient outcomes, and expand accessibility. One of the most promising innovations is closed-loop spinal cord stimulation (SCS). Unlike traditional systems that provide constant stimulation, closed-loop SCS continuously adjusts therapy in real-time based on evoked compound action potentials (ECAPs). This allows the device to respond to the patient’s physiological changes, ensuring more effective pain relief and functional improvements. Dr. Matis had the opportunity to implant the first closed-loop system in 2020, and the long-term success observed in patients has reinforced his confidence in this technology. Artificial intelligence (AI) is also bringing a new level of precision to SCS programming. Traditionally, adjusting stimulation parameters has been a trial-and-error process, but AI is changing that by analyzing vast datasets to tailor therapy for each patient. This ensures more accurate, dynamic, and effective pain management while reducing the burden on both patients and clinicians. As AI continues to advance, neuromodulation is moving toward truly personalized treatment approaches. As Hippocrates once said, “Wherever the art of medicine is loved, there is also a love of humanity.” These advancements reflect that philosophy by making neuromodulation more adaptive, intelligent, and patient-focused. While technology continues to evolve, the ultimate goal remains the same: to restore function, alleviate suffering, and improve the quality of life for those living with chronic pain. Advancing Pain Management: A Future of Precision and Collaboration The treatment of chronic pain and spasticity faces significant challenges, particularly in access to advanced therapies, patient-specific treatment optimization, and interdisciplinary collaboration. While neuromodulation and interventional pain management have made remarkable progress, many patients still encounter delays in receiving these treatments. Limited awareness, restrictive healthcare policies, and inconsistencies in insurance coverage often create barriers to timely care. Despite the availability of advanced technologies, integrating them effectively into clinical practice remains a hurdle, leaving many patients without the relief they could potentially achieve. A major challenge in pain management is ensuring that therapies are tailored to individual patients. Chronic pain and spasticity are complex conditions that require a multimodal approach, yet treatment selection and programming often lack the necessary precision. Understanding neurophysiological mechanisms and patient-reported outcomes is essential to refining these treatments. Without a personalized approach, even the most advanced therapies may fail to provide optimal relief. Looking ahead, the next decade promises transformative change in pain medicine. Technological advancements will continue to shape the field, with closed-loop neuromodulation, AI-driven programming, and combination therapies offering more precise and adaptive treatments. The integration of neurostimulation with pharmacological and rehabilitative strategies will improve patient outcomes while minimizing side effects. As these innovations emerge, collaboration among neurosurgeons, pain specialists, physiatrists, and engineers will become even more essential. A stronger emphasis on education and teamwork will help bridge the gap between research and clinical application, ensuring that cutting-edge treatments reach the patients who need them most. The Power of Collaboration in Advancing Neuromodulation According to
Georgios Matis – Top Global Advocate for Neuromodulation Excellence of the Year 2025 Read More »